Development of Vaccines against HIV/AIDS in European Networks

被引:0
|
作者
Wolf, Hans [1 ]
机构
[1] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:326 / 326
页数:1
相关论文
共 50 条
  • [41] Migrants against HIV/AIDS
    Makulowich, JS
    AIDS PATIENT CARE AND STDS, 1996, 10 (02) : 139 - 139
  • [42] WHERE ARE WE NOW WITH VACCINES AGAINST AIDS
    SCHILD, GC
    STOTT, EJ
    BRITISH MEDICAL JOURNAL, 1993, 306 (6883): : 947 - 948
  • [43] AIDS VACCINES - A VACCINE DEVELOPMENT ENIGMA
    DORNER, F
    BARRETT, N
    WIENER KLINISCHE WOCHENSCHRIFT, 1990, 102 (02) : 51 - 58
  • [44] HIV AIDS and development
    Mhaske, DD
    EPIDEMIOLOGY, 2005, 16 (05) : S160 - S160
  • [45] HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development
    Caputo, Antonella
    Gavioli, Riccardo
    Bellino, Stefania
    Longo, Olimpia
    Tripiciano, Antonella
    Francavilla, Vittorio
    Sgadari, Cecilia
    Paniccia, Giovanni
    Titti, Fausto
    Cafaro, Aurelio
    Ferrantelli, Flavia
    Monini, Paolo
    Ensoli, Fabrizio
    Ensoli, Barbara
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2009, 28 (05) : 285 - 334
  • [46] A MATHEMATICAL-MODEL OF VACCINATION AGAINST HIV TO PREVENT THE DEVELOPMENT OF AIDS
    NOWAK, MA
    MCLEAN, AR
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1991, 246 (1316) : 141 - 146
  • [47] Immunity, immunopathology and vaccines against HIV?
    Zinkernagel, RM
    VACCINE, 2002, 20 (15) : 1913 - 1917
  • [48] Vaccines and vaccine strategies against HIV
    Stratov, I
    DeRose, R
    Purcell, DFJ
    Kent, SJ
    CURRENT DRUG TARGETS, 2004, 5 (01) : 71 - 88
  • [49] THE POTENTIAL OF ANTIIDIOTYPE VACCINES AGAINST HIV
    DALGLEISH, AG
    WILKS, D
    WALKER, L
    HABESHAW, J
    VACCINES FOR SEXUALLY TRANSMITTED DISEASES, 1989, : 257 - 262
  • [50] Therapeutic vaccines against HIV infection
    Garcia, Felipe
    Leon, Agathe
    Gatell, Josep M.
    Plana, Montserrat
    Gallart, Teresa
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (05) : 569 - 581